Keyword: McGill University
Montreal-based NeuroServo is working on a mobile EEG device that could become an objective test for delirium.
The week’s biotech discoveries include an insulin-related gene mutation and the news that previously ignored brain structures could govern obesity.
A new target for the treatment of MeCP2 duplication syndrome could be useful in treating autism and other neurological conditions.
Researchers led by McGill University are investigating whether the diabetes drug metformin might effectively treat fragile X syndrome, a cause of autism.
JDRF and McGill University are joining forces to investigate ways to improve the platform’s glucose control performance.
The major side effects of delivering anti-cancer drugs, systemically, has warranted a more refined targeted approach. Now researchers say they have the answer by successfully targeting cancer cells with nanorobotic agents.